Leucocare AG Martinsried/München News & Veranstaltungen

Press Releases

Jun. 2018

 LEUKOCARE grants a license on its SPS® formulation technology platform to Laboratorios Liomont for development and commercialization of a biosimilar

(more...)
Apr. 2018

 LEUKOCARE and Boehringer Ingelheim enter into a long-term agreement in the field of animal health

(more...)
Mar. 2018

 Rentschler Biopharma and Leukocare demonstrate success of strategic alliance for biopharmaceutical development and formulation

(more...)
Sep. 2017

 LEUKOCARE continues to expand and invests in research and development

(more...)
Back

Publications

Amino acid-based advanced liquid formulation development for highly concentrated therapeutic antibodies balances physical and chemical stability and low viscosity

Biotechnol. J. 2018, 13, 1700523

SCHOLZ M. ET AL.:Amino acid-based advanced liquid formulation development for highly concentrated therapeutic antibodies balances physical and chemical stability and low viscosity

(more...)

PloS ONE

2014 December, PLoS ONE 9(12): e115940. doi:10.1371/journal.pone.

WINDOLF C.D. ET AL.:Lysostaphin-Coated Titan-Implants Preventing Localized Osteitis by Staphyloccus aureus in a Mouse Model (more...)

Human Vaccines & Immunotherapeutics

2014 July; Vol. 10, Issue 10, Meeting Report

DERWAND R.: Annual World Vaccine Congress 2014: A re-evaluation of the value proposition for increasing vaccine thermostability (more...)

Vaccine

2014 April; Vol. 32, Issue 19

SCHERLIESS R. ET AL.: Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates

(more...)

Back

Next Events

Meet us at the following events

Currently there are no events.
Back